| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb8f3eba86915d967beefc175437273a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1018 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2012-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d8aca7db69027f7ce22803b9c3ed481
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cb92c358c5fbd31dfbc5dfcf567e5cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c28f797cde0fa6a2299ea160b32ecafb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c04c6156f29a24130baa196f33e8b5df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50e6b7c4136ebdaf826f9ec382695c75 |
| publicationDate |
2017-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-106872702-A |
| titleOfInvention |
Cell-free PSA Antibody for Diagnosis, Prognosis and Treatment of Prostate Cancer |
| abstract |
The present invention provides methods of monitoring and detecting tumor-associated free PSA ("fPSA") using antibody polypeptides as indicators of androgen receptor signaling. In specific embodiments, the method can be used to assess the effectiveness of anti-androgens and/or anti-cancer treatments in general. The invention also provides various methods and compositions involving fPSA-specific antibodies that bind to tumors or that are intratumoral. For example, the invention provides compositions, including pharmaceutical compositions, comprising anti-fPSA antibodies or fragments or characteristic portions thereof. The invention further provides various therapeutic and/or diagnostic methods using anti-fPSA antibodies and/or compositions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114324526-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108802392-A |
| priorityDate |
2011-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |